Frequently Asked Questions What is AOD 9604
On July 23 and 24, 2026, the Pharmacy Compounding Advisory Committee will vote on whether these compounds can remain available through compounding pharmacies
Then 1,3 BPG becomes 2,3 BPG, which helps in unloading oxygen to tissues
J Personalized Med 2024;14(5):489
ability to travel long distances through tissues due to low molecular weight Combined administration: Theoretical coverage of both local (BPC-157) and systemic (TB-500) healing requirements Metabolism & Elimination The metabolic fates of both peptides show significant differences that may influence combination dosing strategies[20,21]: BPC-157 plasma half-life : Under 30 minutes in dog and rat models
The votes were nonbinding, and final FDA action remained pending as of July 26, 2026